Mikkael Sekkeres, M.D.

Cleveland Clinic Foundation/Taussig Cancer CenterCleveland, Ohio - 44195 (216-445-9395) |
- CLINICAL TRIALS 1
- CONDITIONS7
- INTERVENTIONS1
- SINCE2009

Dose Finding Study of Panobinostat Given in Combination With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS) Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML)
December 2009 - December 2011
Leukemia
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Leukemia, Myelomonocytic, Acute
Leukemia, Myelomonocytic, Chronic
Panobinostat (Lbh589) And 5-Azacytidine (Vidaza®)



